Cite

HARVARD Citation

    Shen, Z. et al. (2022). Hypoxia-inducible factor-1α inhibition augments efficacy of programmed cell death 1 antibody in murine prostatic cancer models. Anti-cancer drugs. 33 (6), pp. 587-594. [Online]. 
  
Back to record